CORC

在结果中检索

CORC

浏览/检索结果: 共28条，第1-10条 帮助

限定条件                
已选(0)清除 条数/页：   排序方式：
Treatment of relapsed or refractory classical Hodgkin lymphoma with the anti-PD-1, tislelizumab: results of a phase 2, single-arm, multicenter study 期刊论文
2019
作者:  Song Yuqin;  Gao Quanli;  Zhang Huilai;  Fan Lei;  Zhou Jianfeng
收藏  |  浏览/下载：16/0  |  提交时间：2020/01/03
Sirt6 regulates efficiency of mouse somatic reprogramming and maintenance of pluripotency 期刊论文
2019, 卷号: 10, 期号: 1, 页码: 9
作者:  Xu, Peng;  Wang, Ting-ting;  Liu, Xiu-zhen;  Wang, Nan-Yu;  Sun, Li-hong
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Secretory status of monoclonal immunoglobulin is related to the outcome of patients with myeloma: a retrospective study 期刊论文
2019, 卷号: 3, 期号: 5, 页码: 751-760
作者:  Qin Xiao-Qi;  An Gang;  Li Zeng-Jun;  Liu Lan-Ting;  Xu Yan
收藏  |  浏览/下载：13/0  |  提交时间：2020/01/03
Adventitial Cell Atlas of wt (Wild Type) and ApoE (Apolipoprotein E)-Deficient Mice Defined by Single-Cell RNA Sequencing 期刊论文
2019, 卷号: 39, 期号: 6, 页码: 1055-1071
作者:  Gu, Wenduo;  Ni, Zhichao;  Tan, Yuan-Qing;  Deng, Jiacheng;  Zhang, Si-Jin
收藏  |  浏览/下载：12/0  |  提交时间：2020/01/03
Ibrutinib versus rituximab in relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma: a randomized, open-label phase 3 study 期刊论文
2018, 卷号: 7, 期号: 4, 页码: 1043-1055
作者:  Huang, Xiaojun;  Qiu, Lugui;  Jin, Jie;  Zhou, Daobin;  Chen, Xiequn
收藏  |  浏览/下载：9/0  |  提交时间：2020/01/03
Metformin suppresses melanoma progression by inhibiting KAT5-mediated SMAD3 acetylation, transcriptional activity and TRIB3 expression 期刊论文
2018, 卷号: 37, 期号: 22, 页码: 2967-2981
作者:  Li, Ke;  zhang, Ting-ting;  Wang, Feng;  Cui, Bing;  Zhao, Chen-xi
收藏  |  浏览/下载：1/0  |  提交时间：2020/01/03
TRIB3通过维持原癌蛋白PML-RARα的稳定性、抑制p53介导的抗癌作用,促进急性早幼粒白血病的发病及疾病进展 期刊论文
2018, 期号: 04, 页码: 52
作者:  李珂;  王凤;  Wen-Bin Cao;  Xiao-Xi Lv;  Fang Hua
收藏  |  浏览/下载：5/0  |  提交时间：2020/01/03
Total Synthesis of Originally Proposed and Revised Structure of Hetiamacin A 期刊论文
2018, 卷号: 20, 期号: 12, 页码: 3566-3569
作者:  Wu, Gang;  Liu, Shaowei;  Wang, Ting;  Jiang, Zhongke;  Lv, Kai
收藏  |  浏览/下载：3/0  |  提交时间：2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 期刊论文
2018, 卷号: 132
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：8/0  |  提交时间：2020/01/03
Tislelizumab (BGB-A317) for Relapsed/Refractory Classical Hodgkin Lymphoma: Preliminary Efficacy and Safety Results from a Phase 2 Study 会议论文
BLOOD, 2018-11-29
作者:  Song, Yuqin;  Gao, Quanli;  Zhang, Huilai;  Fan, Lei;  Zhou, Jianfeng
收藏  |  浏览/下载：15/0  |  提交时间：2020/01/03

©版权所有 ©2017 CSpace - Powered by CSpace